BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed LRMR catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:f9eeb46d998eb7387f00@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:LRMR P2 readout (est.): An Open-Label Study of CTI-1601 in Subjects
  With Friedreich's Ataxia
DESCRIPTION:An Open-Label Study of CTI-1601 in Subjects With Friedreich's A
 taxia\nNCT06447025 | PHASE2 | RECRUITING | sponsor: Larimar Therapeutics\,
  Inc.\nPrimary completion date (ESTIMATED)\; top-line results usually foll
 ow later.\nDate precision: month (shown on the first day)\nTicker LRMR (co
 nfidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT06447025\nSched
 uling/reference data from public records\; dates can move. Not investment\
 , legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06447025
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
